Jul 7, 2008
Story Timeline: 100 days
Silicon Valley / San Jose Business Journal on Monday named Ronald J. Prentki president, chief executive and a member of the company's board, succeeding former CEO Gregory Turnbull, who will remain a company director and member of the board's executive committee. The Redwood City-based specialty pharmaceutical company said Turnbull will also be interim chief financial officer until a permanent successor is recruited. "I am delighted to welcome Ron Prentki as our new CEO. Ron brings a wealth of experience in business development, commercialization and general management to A.P. Pharma," company Chairman Dr. Paul Goddard. "We believe that Ron will provide the strong leadership we need as we further develop a pipeline of products based upon our bioerodible drug delivery system and in particular, our lead product APF530, for the...
[read full story]